<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01163422</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 09/307</org_study_id>
    <nct_id>NCT01163422</nct_id>
  </id_info>
  <brief_title>Right Ventricular Resynchronization Therapy</brief_title>
  <acronym>RVRT</acronym>
  <official_title>Long-term Right Ventricular Resynchronization Therapy for Chronic Thromboembolic Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether cardiac resynchronization therapy with the
      use of an implanted electronic pacemaker reduces morbidity associated with chronic
      thromboembolic pulmonary hypertension
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: The clinical severity of right ventricular disease is largely determined by
      right-to-left ventricular dyssynchrony, i.e., delay of electrical activity between the right
      and left ventricles. Moreover, in patients with chronic thromboembolic pulmonary hypertension
      (CTEPH), we found that acute correction of this dyssynchrony by temporary pacing (prior to
      pulmonary endarterectomy, presently the therapy of choice for CTEPH) results in significant
      improvement in cardiac output. In this study, we aim to establish whether chronic pacing with
      the use of implanted pacemakers confers long-lasting improvements in cardiac output and
      functional class.

      Objective: To study whether chronic pacing with implanted pacemakers confers long-lasting
      improvements in cardiac output and functional class in severely symptomatic CTEPH patients
      who are not eligible for pulmonary endarterectomy, or those in whom pulmonary endarterectomy
      has failed.

      Study design: Chronic intervention study, double-blinded, randomized, cross-over.

      Study population: Adult CTEPH patients who are not eligible for pulmonary endarterectomy, or
      those in whom pulmonary endarterectomy has failed.

      Intervention (if applicable): chronic right ventricular resynchronization therapy (RVRT),
      i.e., chronic right atrial, right ventricular, and left ventricular pacing with the use of
      implanted pacemakers.

      Main study parameters/endpoints: (Duration of) improvements (in l/min) in cardiac output as
      measured using Doppler echocardiography, and functional class as measured using 6-minute
      walking distance (6-MWD), right and left ventricular dimensions and ejection fractions
      (99mTechnetium scintigraphy), biomarkers for heart failure (serum NT-proBNP levels), and
      quality of life (SF-36) questionnaire.

      Design: Randomized, double-blind, cross-over study with 2 arms of 10 patients each (arms 1
      and 2). In arm 1, RVRT is switched on immediately after pacemaker implant, is switched of in
      week 5, and switched on at the start of week 6 until study end (32 weeks). In arm 2, RVRT is
      switched at the start of week 5 after pacemaker implant until study end (32 weeks). At
      various follow-up visits at weeks 1, 4, 5, 6, 8, 12, 16, the main study parameters/endpoints
      (see previous paragraph) will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>July 2010</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in right/left ventricular synchrony measured using tissue Doppler echocardiography</measure>
    <time_frame>within 8 months after pacemaker implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in cardiac output measured using Doppler echocardiography and scintigraphy</measure>
    <time_frame>within 8 months after pacemaker implantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in functional capacity measured with six-minute walking distance</measure>
    <time_frame>within 8 months after pacemaker implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in well-being assessed with questionnaire</measure>
    <time_frame>within 8 months after pacemaker implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Right Ventricular Failure</condition>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Immediate RVRT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RVRT switched on immediately after pacemaker implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed RVRT</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>RVRT switched on 4 weeks after pacemaker implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of 3-chamber pacemaker</intervention_name>
    <description>Implantation of pacemaker with leads in right atrium, right ventricle, and coronary sinus (left ventricle) with the aim of providing right ventricular resynchronization therapy (RVRT); this is accomplished by pacing the right ventricle ahead of the left ventricle, e.g., by setting (shortening) the A-V delay between right atrium and right ventricle to an optimal level.</description>
    <arm_group_label>Immediate RVRT</arm_group_label>
    <arm_group_label>Delayed RVRT</arm_group_label>
    <other_name>Medtronic CRT pacemaker systems will be implanted</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are
        ineligible for pulmonary endarterectomy, and those in whom pulmonary endarterectomy has
        failed

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanno L Tan, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academic Medical Center, University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2010</study_first_submitted>
  <study_first_submitted_qc>July 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2010</study_first_posted>
  <last_update_submitted>July 14, 2010</last_update_submitted>
  <last_update_submitted_qc>July 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Hanno L. Tan, MD, PhD</name_title>
    <organization>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</organization>
  </responsible_party>
  <keyword>Right ventricular failure</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>Cardiac resynchronization therapy</keyword>
  <keyword>Pulmonary hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

